A placebo-controlled study of growth hormone in patients with congestive heart failure.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  European Heart Journal

• Publication date

  1998-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/EUHJ.1998.1123PMID 9857924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth Hormone and the Heart

  1999cited by this paper
• Growth hormone improves cardiac function in rats with experimental myocardial infarction

  1997cited by this paper
• Haemodynamic effects of intravenous growth hormone in congestive heart failure.

  1997cited by this paper
• Treatment of end-stage cardiac failure with growth hormone.

  1997cited by this paper
• Exogenously administered growth hormone and insulin-like growth factor-I alter intracellular Ca2+ handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart.

  1996cited by this paper
• Growth hormone in the treatment of dilated cardiomyopathy.

  1996cited by this paper
• Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation.

  1996cited by this paper
• A preliminary study of growth hormone in the treatment of dilated cardiomyopathy.

  1996influential reference
• GH replacement fails to improve ventricular function in hypophysectomized rats with myocardial infarction.

  1996cited by this paper
• Growth hormone in the treatment of dilated cardiomyopathy.

  1996cited by this paper
• The management of chronic heart failure.

  1996cited by this paper
• Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat.

  1996cited by this paper
• Long‐term cardiovascular effects of growth hormone treatment in GH‐deficient adults Preliminary data in a small group of patients

  1996cited by this paper
• Growth Hormone Improves Cardiac Performance in Experimental Heart Failure

  1995cited by this paper
• Beneficial Effects of Growth Hormone and Insulin‐Like Growth Factor‐1 in Experimental Heart Failure in Rats Treated with Chronic ACE Inhibition

  1995cited by this paper
• Growth hormone improves cardiac performance in experimental heart failure.

  1995cited by this paper
• Growth hormone and the heart.

  1994cited by this paper
• Cardiovascular and renal effects of growth hormone *

  1994cited by this paper
• Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses.

  1993cited by this paper
• Reversible dilated cardiomyopathy due to growth hormone deficiency.

  1992cited by this paper
• Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle.

  1990cited by this paper
• Left ventricular volume calculation using a count-based ratio method applied to first-pass radionuclide angiography.

  1990cited by this paper
• Left ventricular volume calculation using a count-based ratio method applied to multigated radionuclide angiography.

  1990cited by this paper
• Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

  1989cited by this paper
• Cardiac failure responding to growth hormone.

  1989cited by this paper
• Dyspnoea of cardiac origin in 67 year old men: (2). Relation to diastolic left ventricular function and mass. The study of men born in 1913.

  1988cited by this paper
• Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion.

  1988cited by this paper
• Dyspnoea of cardiac origin in 67 year old men: (1). Relation to systolic left ventricular function and wall stress. The study of men born in 1913.

  1988cited by this paper
• Heart Disease: A Textbook of Cardiovascular Medicine

  1984cited by this paper
• Acid-citrate-dextrose compared with heparin in the preparation of in vivo/in vitro technetium-99m red blood cells.

  1983cited by this paper
• Noninvasive Determination of Left Ventricular End‐systolic Stress: Validation of the Method and Initial Application

  1982cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper
• Cardiovascular survey methods.

  1969cited by this paper
• Letter to the editor

  1967cited by this paper

• Cardiovascular Effects of Growth Hormone: From Deficiency to Acromegaly.

  2026cites this paper
• Cardiac Cachexia and the Associations to the Microbiome: State‐of‐the‐Science Review

  2025cites this paper
• Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancer

  2024cites this paper
• GH Therapy in Chronic Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  2024cites this paper
• Growth Hormone and Heart Failure: Implications for Patient Stratification, Prognosis, and Precision Medicine

  2024influential citation
• The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency

  2024cites this paper
• Exercise Promotes Tissue Regeneration: Mechanisms Involved and Therapeutic Scope

  2023cites this paper
• Anabolic Deficiencies in Heart Failure: Ready for Prime Time?

  2022cites this paper
• Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis

  2022cites this paper
• The Effect of 3-Month Growth Hormone Administration and 12-Month Follow-Up Duration among Heart Failure Patients Four Weeks after Myocardial Infarction: A Randomized Double-Blinded Clinical Trial

  2021influential citation
• Recombinant Human Growth Hormone Inhibits Lipotoxicity, Oxidative Stress, and Apoptosis in a Mouse Model of Diabetic Cardiomyopathy

  2021cites this paper
• Effect of growth hormone treatment on circulating levels of NT-proBNP in patients with ischemic heart failure.

  2020cites this paper
• [Cachexia].

  2020cites this paper
• Growth factor therapy for cardiac repair: an overview of recent advances and future directions

  2020cites this paper
• Anabolic Deficiencies in Heart Failure: Ready for Prime Time?

  2020cites this paper
• Electrophysiologic Effects of Growth Hormone Post-Myocardial Infarction

  2020cites this paper
• Acromegaly and Heart Failure.

  2019cites this paper
• Hormonal Replacement Therapy in Heart Failure: Focus on Growth Hormone and Testosterone.

  2019cites this paper
• New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure

  2019cites this paper
• Hormone treatments in congestive heart failure

  2018cites this paper
• Growth Hormone Therapy in Heart Failure.

  2018cites this paper
• Growth Hormone as Biomarker in Heart Failure.

  2018cites this paper
• The impairment of the Growth Hormone/Insulin-like growth factor 1 (IGF-1) axis in heart failure: A possible target for future therapy.

  2018cites this paper
• Effects of growth hormone on cardiac remodeling and soleus muscle in rats with aortic stenosis-induced heart failure

  2017cites this paper
• Insights from Second-Line Treatments for Idiopathic Dilated Cardiomyopathy

  2017cites this paper
• Sex Differences in Muscle Wasting.

  2017cites this paper
• P1105Recombinant insulin-like growth factor-1 improves cardiac function and symptoms in the patients on the waiting list for heart transplantation with end-stage dilated cardiomyopathy

  2017cites this paper
• Muscle wasting and cachexia in heart failure: mechanisms and therapies

  2017cites this paper
• Plasma growth hormone is a strong predictor of risk at one year in acute heart failure

  2016cites this paper
• Imbalance of catabolic and anabolic pathways in chronic heart failure

  2016cites this paper
• Sarcopenia in heart failure: mechanisms and therapeutic strategies

  2016cites this paper
• Hormone Therapy to Treat Cardiac Remodeling: Is There Any Evidence?

  2016cites this paper
• Cardiac Cachexia: Perspectives for Prevention and Treatment

  2016cites this paper
• Plasma growth hormone is a strong predictor of risk at 1 year in acute heart failure

  2016cites this paper
• Hormonal Profile in Patients With Dilated Cardiomyopathy

  2015cites this paper
• Advanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon?

  2015cites this paper
• Hormone replacement therapy in heart failure

  2015cites this paper
• Administration of a Synthetic Peptide Derived from the E-domain Region of Mechano-Growth Factor Delays Decompensation Following Myocardial Infarction.

  2014cites this paper
• Growth Hormone (GH) and the Cardiovascular System: Studies in Bovine GH Transgenic and Inducible, Cardiac-Specific GH Receptor Gene Disrupted Mice

  2014influential citation
• GH and the cardiovascular system: an update on a topic at heart

  2014cites this paper
• Effects of Hormonal Therapy in Patients with Heart Failure

  2014cites this paper
• Hormonal Therapy in the Treatment of Chronic Heart Failure

  2014cites this paper
• Amino acids and derivatives, a new treatment of chronic heart failure?

  2014cites this paper
• Mechanisms for Cachexia in Heart Failure

  2013cites this paper
• Biochemical Basis and Therapeutic Implications of Angiogenesis

  2013cites this paper
• The GH/IGF-1 axis in chronic heart failure.

  2013cites this paper
• Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study.

  2013cites this paper
• Angiogenesis in Myocardial Ischemia

  2013cites this paper
• New Pain Management Vistas in Palliative Care

  2013cites this paper
• Pre-Weaning Growth Hormone Treatment Reverses Hypertension and Endothelial Dysfunction in Adult Male Offspring of Mothers Undernourished during Pregnancy

  2013cites this paper
• Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease

  2013cites this paper
• Cachexia in chronic heart failure: endocrine determinants and treatment perspectives

  2013cites this paper
• Cardiac PI3Kα Signaling and K+ Channel Regulation in Cardiac Hypertrophy and Heart Failure

  2012cites this paper
• Therapeutic Potential of Ghrelin in the Treatment of Heart Failure

  2012cites this paper
• Ghrelin, appetite and critical illness

  2012cites this paper
• The Potential Effects of IGF-1 and GH on Patients With Chronic Heart Failure

  2012cites this paper
• Hormonal consequences and prognosis of chronic heart failure

  2011cites this paper
• Myths and Truths of Growth Hormone and Testosterone in Heart Failure

  2011cites this paper
• Alterations in Nutrition and Body Mass in Heart Failure

  2011cites this paper
• Myths and truths of growth hormone and testosterone therapy in heart failure

  2011cites this paper
• [Chronic heart failure and cachexia: role of endocrine system].

  2011cites this paper
• Evaluation of pulsatile plasma concentrations of growth hormone in healthy dogs and dogs with dilated cardiomyopathy.

  2011cites this paper
• Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease.

  2010cites this paper
• Pathological changes and clinical use of the measurement of serum/plasma concentrations of insulin-like growth factor type 1 (IGF-1) in horses, dogs and cats.

  2010cites this paper
• Growth hormone and testosterone in heart failure therapy

  2010cites this paper
• Cardiac Cachexia in Chronic Heart Failure: The Metabolic Facet of CHF

  2010cites this paper
• Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting.

  2010cites this paper
• Growth hormone attenuates skeletal muscle changes in experimental chronic heart failure.

  2010cites this paper
• Squilibrio Anabolico/Catabolico nello Scompenso Cardiaco Cronico Anabolic/Catabolic Imbalance in Chronic Heart Failure

  2010cites this paper
• Von der Herzinsuffizienz zur kardialen Kachexie: Klinik und pathophysiologische Mechanismen

  2009cites this paper
• Nutrition and heart failure: impact of drug therapies and management strategies.

  2009cites this paper
• The GH/IGF-1 Axis and Heart Failure

  2009cites this paper
• No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure.

  2009cites this paper
• Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure.

  2009cites this paper
• III Diretriz Brasileira de Insuficiência Cardíaca Crônica

  2009cites this paper
• Overview of emerging pharmacotherapy in chronic heart failure

  2009cites this paper
• Overviewofemerging pharmacotherapyinchronic heartfailure

  2009cites this paper
• Inter-relações e variabilidade do estado nutricional, colesterolemia, actividade neuro-humoral e pró-inflamatória na Insuficiência Cardíaca

  2009cites this paper
• GROWTH HORMONE ATTENUATES MYOCARDIAL FIBROSIS IN RATS WITH CHRONIC PRESSURE OVERLOAD‐INDUCED LEFT VENTRICULAR HYPERTROPHY

  2009cites this paper
• Cardiac cachexia: a systematic overview.

  2009cites this paper
• [III Brazilian Guidelines on Chronic Heart Failure].

  2009cites this paper
• Growth hormone and heart failure: oxidative stress and energetic metabolism in rats.

  2008cites this paper
• Antiarrhythmic effects of growth hormone--in vivo evidence from small-animal models of acute myocardial infarction and invasive electrophysiology.

  2008cites this paper
• Relative cardiac expression of growth hormone receptor and insulin-like growth factor-I mRNA in congenital heart disease

  2008cites this paper
• Growth hormone therapy in congestive heart failure due to left ventricular systolic dysfunction: a meta-analysis.

  2008cites this paper
• Myocardial metabolism in experimental infarction and heart failure

  2008cites this paper
• Aging and the Cardiovascular-Related Systems

  2008cites this paper
• Role of IGF-1 in glucose regulation and cardiovascular disease

  2008cites this paper
• Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis.

  2007influential citation
• Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.

  2007cites this paper
• Metabolic perturbation in chronic heart failure: time to redress the balance?

  2007cites this paper
• Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart.

  2007cites this paper
• Pharmacologic therapy in growth hormone disorders and the heart.

  2007cites this paper
• Metabolic perturbation in chronic heart failure: time to redress the balance?

  2007cites this paper
• Effects of growth hormone on exercise capacity and cardiopulmonary performance in patients with chronic heart failure.

  2007cites this paper
• Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment

  2007cites this paper
• Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.

  2007cites this paper
• The GH/IGF-1 system during surgery and catabolism : Focus on metabolism and heart function

  2007cites this paper
• Growth hormone, vascular reactivity, and heart failure

  2006cites this paper
• Ghrelin: Its Therapeutic Potential in Heart Failure

  2006cites this paper